Assessed whether engineering pathogens capable of "sustained, human-to-human transmission and causing mortality and morbidity" is possible/probable. Also considers how such pathogens would compare to naturally emergent pathogens in these regards, the…
This report assesses the utility of multi-criteria decision analysis (MCDA) and decision support framework (DSF) in assisting the US Department of Agriculture in its reviews of select agents. It uses the method to assess 41 pathogens against 21…
Author surveys bioweapons experts to roadmap the most important historical trends surrounding bioweapon risk and policy (motivators, inhibitors, drivers, wild cards) from the 1940s to present day. With this information, the author attempts to create…
This is the third edition of Medical Aspects of Biological Warfare and aims to highlight the current state of science on individual agents and toxins and general response capabilities to prevent knowledge gaps and serve as a reference source for the…
This hearing before the Subcommittee on Intelligence, Emerging Threats, and Capabilities discussed the threat of biological weapons attacks from state and nonstate actors.
The purpose of this handbook is to serve as a concise, pocket-sized manual that can be used in a crisis to guide medical personnel in the prophylaxis and management of biological casualties.
This document discusses the conflict between open scientific communication and national security in the biosciences in order to contribute to the national dialogue on the costs and benefits of regulatory regimes.
This hearing before the Subcommittee on Bioterrorism and Public Health Preparedness aims to assess current biological threats in order to decide the necessary countermeasures to be developed.
This report assesses the threat posed by small-scale terrorist attacks using biological, chemical, and toxin agents rather than traditional risk assessments which focus on mass casualty attacks.
The report assesses the health aspects of the threat of biological and chemical weapons, including specific agents, focusing on civilian impacts. It then makes recommendations for preparedness and prevention of attacks.
This progress report details the progress of the National Institute of Allergy and Infectious Diseases towards the recommendations made by the Blue Ribbon Panel on Bioterrorism and Its Implications for Biomedical Research in February 2002. These…
This hearing before the Committee on Foreign Relations held two panels to discuss the threat of biological weapons use and emerging infectious diseases, calling on experts in both fields. The first panel was centered on a smallpox simulation known as…
In the wake of the 9/11 terrorist attacks, the Subcommittee of the Committee on Appropriations discusses US preparedness for a bioterrorism event in a series of hearings over a few weeks.
This report of the Scientific Advisory Board discusses ricin production, the meaning of "production by synthesis", a progress report on CW destruction matters, and a few other issues.